A citation-based method for searching scientific literature

Marco Lo Iacono, Valentina Monica, Luisella Righi, Federica Grosso, Roberta Libener, Simona Vatrano, Paolo Bironzo, Silvia Novello, Loredana Musmeci, Marco Volante, Mauro Papotti, Giorgio V Scagliotti. J Thorac Oncol 2015
Times Cited: 98







List of co-cited articles
936 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma.
Guangwu Guo, Juliann Chmielecki, Chandra Goparaju, Adriana Heguy, Igor Dolgalev, Michele Carbone, Sara Seepo, Matthew Meyerson, Harvey I Pass. Cancer Res 2015
196
59

Germline BAP1 mutations predispose to malignant mesothelioma.
Joseph R Testa, Mitchell Cheung, Jianming Pei, Jennifer E Below, Yinfei Tan, Eleonora Sementino, Nancy J Cox, A Umran Dogan, Harvey I Pass, Sandra Trusa,[...]. Nat Genet 2011
634
53

The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma.
Matthew Bott, Marie Brevet, Barry S Taylor, Shigeki Shimizu, Tatsuo Ito, Lu Wang, Jenette Creaney, Richard A Lake, Maureen F Zakowski, Boris Reva,[...]. Nat Genet 2011
461
52

Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations.
Raphael Bueno, Eric W Stawiski, Leonard D Goldstein, Steffen Durinck, Assunta De Rienzo, Zora Modrusan, Florian Gnad, Thong T Nguyen, Bijay S Jaiswal, Lucian R Chirieac,[...]. Nat Genet 2016
455
52

High Incidence of Somatic BAP1 alterations in sporadic malignant mesothelioma.
Masaki Nasu, Mitsuru Emi, Sandra Pastorino, Mika Tanji, Amy Powers, Hugh Luk, Francine Baumann, Yu-An Zhang, Adi Gazdar, Shreya Kanodia,[...]. J Thorac Oncol 2015
189
41

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.
Nicholas J Vogelzang, James J Rusthoven, James Symanowski, Claude Denham, E Kaukel, Pierre Ruffie, Ulrich Gatzemeier, Michael Boyer, Salih Emri, Christian Manegold,[...]. J Clin Oncol 2003
36

BAP1 and cancer.
Michele Carbone, Haining Yang, Harvey I Pass, Thomas Krausz, Joseph R Testa, Giovanni Gaudino. Nat Rev Cancer 2013
388
25

Frequent inactivation of the BAP1 gene in epithelioid-type malignant mesothelioma.
Yoshie Yoshikawa, Ayuko Sato, Tohru Tsujimura, Mitsuru Emi, Tomonori Morinaga, Kazuya Fukuoka, Shusai Yamada, Aki Murakami, Nobuyuki Kondo, Seiji Matsumoto,[...]. Cancer Sci 2012
124
25

Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial.
Gérard Zalcman, Julien Mazieres, Jacques Margery, Laurent Greillier, Clarisse Audigier-Valette, Denis Moro-Sibilot, Olivier Molinier, Romain Corre, Isabelle Monnet, Valérie Gounant,[...]. Lancet 2016
503
24

Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival.
Francine Baumann, Erin Flores, Andrea Napolitano, Shreya Kanodia, Emanuela Taioli, Harvey Pass, Haining Yang, Michele Carbone. Carcinogenesis 2015
140
23

BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs.
Michele Carbone, Laura Korb Ferris, Francine Baumann, Andrea Napolitano, Christopher A Lum, Erin G Flores, Giovanni Gaudino, Amy Powers, Peter Bryant-Greenwood, Thomas Krausz,[...]. J Transl Med 2012
193
21

Evaluation of clonal origin of malignant mesothelioma.
Sabahattin Comertpay, Sandra Pastorino, Mika Tanji, Rosanna Mezzapelle, Oriana Strianese, Andrea Napolitano, Francine Baumann, Tracey Weigel, Joseph Friedberg, Paul Sugarbaker,[...]. J Transl Med 2014
57
33

Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma.
A Napolitano, L Pellegrini, A Dey, D Larson, M Tanji, E G Flores, B Kendrick, D Lapid, A Powers, S Kanodia,[...]. Oncogene 2016
104
19

High-density array-CGH with targeted NGS unmask multiple noncontiguous minute deletions on chromosome 3p21 in mesothelioma.
Yoshie Yoshikawa, Mitsuru Emi, Tomoko Hashimoto-Tamaoki, Masaki Ohmuraya, Ayuko Sato, Tohru Tsujimura, Seiki Hasegawa, Takashi Nakano, Masaki Nasu, Sandra Pastorino,[...]. Proc Natl Acad Sci U S A 2016
93
19

Germline mutation of Bap1 accelerates development of asbestos-induced malignant mesothelioma.
Jinfei Xu, Yuwaraj Kadariya, Mitchell Cheung, Jianming Pei, Jacqueline Talarchek, Eleonora Sementino, Yinfei Tan, Craig W Menges, Kathy Q Cai, Samuel Litwin,[...]. Cancer Res 2014
89
19

Loss of BAP1 function leads to EZH2-dependent transformation.
Lindsay M LaFave, Wendy Béguelin, Richard Koche, Matt Teater, Barbara Spitzer, Alan Chramiec, Efthymia Papalexi, Matthew D Keller, Todd Hricik, Katerina Konstantinoff,[...]. Nat Med 2015
208
17

Combined Genetic and Genealogic Studies Uncover a Large BAP1 Cancer Syndrome Kindred Tracing Back Nine Generations to a Common Ancestor from the 1700s.
Michele Carbone, Erin G Flores, Mitsuru Emi, Todd A Johnson, Tatsuhiko Tsunoda, Dusty Behner, Harriet Hoffman, Mary Hesdorffer, Masaki Nasu, Andrea Napolitano,[...]. PLoS Genet 2015
58
29

BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations.
Marta Cigognetti, Silvia Lonardi, Simona Fisogni, Piera Balzarini, Vilma Pellegrini, Andrea Tironi, Luisa Bercich, Mattia Bugatti, Giulio Rossi, Bruno Murer,[...]. Mod Pathol 2015
152
16

Genome-based Mutational Analysis by Next Generation Sequencing in Patients with Malignant Pleural and Peritoneal Mesothelioma.
Gamze Ugurluer, Kenneth Chang, Mauricio E Gamez, Andrea L Arnett, Ritujith Jayakrishnan, Robert C Miller, Terence T Sio. Anticancer Res 2016
28
57

Integrative Molecular Characterization of Malignant Pleural Mesothelioma.
Julija Hmeljak, Francisco Sanchez-Vega, Katherine A Hoadley, Juliann Shih, Chip Stewart, David Heiman, Patrick Tarpey, Ludmila Danilova, Esther Drill, Ewan A Gibb,[...]. Cancer Discov 2018
258
16

Germline mutations in BAP1 predispose to melanocytic tumors.
Thomas Wiesner, Anna C Obenauf, Rajmohan Murali, Isabella Fried, Klaus G Griewank, Peter Ulz, Christian Windpassinger, Werner Wackernagel, Shea Loy, Ingrid Wolf,[...]. Nat Genet 2011
467
15

Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer.
Y Sekido, H I Pass, S Bader, D J Mew, M F Christman, A F Gazdar, J D Minna. Cancer Res 1995
230
15

Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada.
Jan P van Meerbeeck, Rabab Gaafar, Christian Manegold, Rob J Van Klaveren, Eric A Van Marck, Mark Vincent, Catherine Legrand, Andrew Bottomley, Channa Debruyne, Giuseppe Giaccone. J Clin Oncol 2005
444
15

Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trial.
Lee M Krug, Hedy L Kindler, Hilary Calvert, Christian Manegold, Anne S Tsao, Dean Fennell, Ronny Öhman, Ruth Plummer, Wilfried E E Eberhardt, Kazuya Fukuoka,[...]. Lancet Oncol 2015
119
15

BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesothelioma.
Stephanie M McGregor, Ryan Dunning, Elizabeth Hyjek, Wickii Vigneswaran, Aliya N Husain, Thomas Krausz. Hum Pathol 2015
78
19

Germline BAP1 mutations predispose to renal cell carcinomas.
Tatiana Popova, Lucie Hebert, Virginie Jacquemin, Sophie Gad, Virginie Caux-Moncoutier, Catherine Dubois-d'Enghien, Bénédicte Richaudeau, Xavier Renaudin, Jason Sellers, André Nicolas,[...]. Am J Hum Genet 2013
181
14

Malignant mesothelioma: facts, myths, and hypotheses.
Michele Carbone, Bevan H Ly, Ronald F Dodson, Ian Pagano, Paul T Morris, Umran A Dogan, Adi F Gazdar, Harvey I Pass, Haining Yang. J Cell Physiol 2012
233
14

Tumor suppressor and deubiquitinase BAP1 promotes DNA double-strand break repair.
Helen Yu, Helen Pak, Ian Hammond-Martel, Mehdi Ghram, Amélie Rodrigue, Salima Daou, Haithem Barbour, Luc Corbeil, Josée Hébert, Elliot Drobetsky,[...]. Proc Natl Acad Sci U S A 2014
217
14

Genomic Landscape of Malignant Mesotheliomas.
Shumei Kato, Brett N Tomson, Timon P H Buys, Sheryl K Elkin, Jennifer L Carter, Razelle Kurzrock. Mol Cancer Ther 2016
40
35

Clinical characteristics of patients with malignant pleural mesothelioma harboring somatic BAP1 mutations.
Marjorie G Zauderer, Matthew Bott, Robert McMillan, Camelia S Sima, Valerie Rusch, Lee M Krug, Marc Ladanyi. J Thorac Oncol 2013
55
23

Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey.
I Roushdy-Hammady, J Siegel, S Emri, J R Testa, M Carbone. Lancet 2001
164
13

BAP1 protein is a progression factor in malignant pleural mesothelioma.
Lisa Arzt, Franz Quehenberger, Iris Halbwedl, Thomas Mairinger, Helmut H Popper. Pathol Oncol Res 2014
54
24

B7-H1 expression in malignant pleural mesothelioma is associated with sarcomatoid histology and poor prognosis.
Aaron Scott Mansfield, Anja C Roden, Tobias Peikert, Yuri M Sheinin, Susan M Harrington, Christopher J Krco, Haidong Dong, Eugene D Kwon. J Thorac Oncol 2014
155
13

A mesothelioma epidemic in Cappadocia: scientific developments and unexpected social outcomes.
Michele Carbone, Salih Emri, A Umran Dogan, Ian Steele, Murat Tuncer, Harvey I Pass, Y Izzettin Baris. Nat Rev Cancer 2007
138
13

Asbestos is not just asbestos: an unrecognised health hazard.
Francine Baumann, Jean-Paul Ambrosi, Michele Carbone. Lancet Oncol 2013
94
12

BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression.
D E Jensen, M Proctor, S T Marquis, H P Gardner, S I Ha, L A Chodosh, A M Ishov, N Tommerup, H Vissing, Y Sekido,[...]. Oncogene 1998
512
12

Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers.
Mohamed H Abdel-Rahman, Robert Pilarski, Colleen M Cebulla, James B Massengill, Benjamin N Christopher, Getachew Boru, Peter Hovland, Frederick H Davidorf. J Med Genet 2011
302
12

Erionite exposure in North Dakota and Turkish villages with mesothelioma.
Michele Carbone, Y Izzettin Baris, Pietro Bertino, Brian Brass, Sabahattin Comertpay, A Umran Dogan, Giovanni Gaudino, Sandro Jube, Shreya Kanodia, Charles R Partridge,[...]. Proc Natl Acad Sci U S A 2011
109
12


Consensus Report of the 2015 Weinman International Conference on Mesothelioma.
Michele Carbone, Shreya Kanodia, Ann Chao, Aubrey Miller, Anil Wali, David Weissman, Alex Adjei, Francine Baumann, Paolo Boffetta, Brenda Buck,[...]. J Thorac Oncol 2016
91
13

BAP1 loss defines a new class of renal cell carcinoma.
Samuel Peña-Llopis, Silvia Vega-Rubín-de-Celis, Arnold Liao, Nan Leng, Andrea Pavía-Jiménez, Shanshan Wang, Toshinari Yamasaki, Leah Zhrebker, Sharanya Sivanand, Patrick Spence,[...]. Nat Genet 2012
604
11

Analysis of expression of programmed cell death 1 ligand 1 (PD-L1) in malignant pleural mesothelioma (MPM).
Susana Cedrés, Santiago Ponce-Aix, Jon Zugazagoitia, Irene Sansano, Ana Enguita, Alejandro Navarro-Mendivil, Alex Martinez-Marti, Pablo Martinez, Enriqueta Felip. PLoS One 2015
132
11

Phase II clinical trial of amatuximab, a chimeric antimesothelin antibody with pemetrexed and cisplatin in advanced unresectable pleural mesothelioma.
Raffit Hassan, Hedy L Kindler, Thierry Jahan, Lyudmila Bazhenova, Martin Reck, Anish Thomas, Ira Pastan, Jeff Parno, Daniel J O'Shannessy, Penny Fatato,[...]. Clin Cancer Res 2014
111
11

p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma.
J Q Cheng, S C Jhanwar, W M Klein, D W Bell, W C Lee, D A Altomare, T Nobori, O I Olopade, A J Buckler, J R Testa. Cancer Res 1994
328
11

Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
P Baas, D Fennell, K M Kerr, P E Van Schil, R L Haas, S Peters. Ann Oncol 2015
194
11

Gender-Specific Molecular and Clinical Features Underlie Malignant Pleural Mesothelioma.
Assunta De Rienzo, Michael A Archer, Beow Y Yeap, Nhien Dao, Daniele Sciaranghella, Antonios C Sideris, Yifan Zheng, Alexander G Holman, Yaoyu E Wang, Paola S Dal Cin,[...]. Cancer Res 2016
44
25

Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study.
Tom Treasure, Loic Lang-Lazdunski, David Waller, Judith M Bliss, Carol Tan, James Entwisle, Michael Snee, Mary O'Brien, Gill Thomas, Suresh Senan,[...]. Lancet Oncol 2011
434
11


Germline BAP1 Mutational Landscape of Asbestos-Exposed Malignant Mesothelioma Patients with Family History of Cancer.
Jill A Ohar, Mitchell Cheung, Jacqueline Talarchek, Suzanne E Howard, Timothy D Howard, Mary Hesdorffer, Hongzhuang Peng, Frank J Rauscher, Joseph R Testa. Cancer Res 2016
61
18

The Genetic Landscape of Malignant Pleural Mesothelioma: Results from Massively Parallel Sequencing.
Marieke Hylebos, Guy Van Camp, Jan P van Meerbeeck, Ken Op de Beeck. J Thorac Oncol 2016
52
21


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.